Sana Biotechnology (SANA) Other financing activities (2020 - 2026)

Sana Biotechnology (SANA) has 7 years of Other financing activities data on file, last reported at $59000.0 in Q1 2026.

• For the quarter ending Q1 2026, Other financing activities fell 94.76% year-over-year to $59000.0; the trailing twelve-month figure through Mar 2026 stood at $1.6 million (down 77.68% YoY), and the FY2025 full-year result was $2.7 million, down 75.68% from the prior year.
• Other financing activities eased to $59000.0 in Q1 2026, from $1.1 million in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $4.9 million in Q1 2024 to a low of $59000.0 in Q1 2026.
• A 5-year average of $1.3 million and a median of $1.1 million in 2025 frame the typical range for Other financing activities.
• Across the five-year window, Other financing activities tumbled 99.9% in 2022 and surged 1988.56% in 2024, its largest moves.
• Tracing SANA's Other financing activities over 5 years: stood at $1.2 million in 2022, then soared by 44.17% to $1.7 million in 2023, then tumbled by 59.05% to $699000.0 in 2024, then soared by 51.5% to $1.1 million in 2025, then slumped by 94.43% to $59000.0 in 2026.
• Business Quant data shows SANA's Other financing activities at $59000.0 in Q1 2026, $1.1 million in Q4 2025, and $157000.0 in Q3 2025.